ArticleBleeding, thrombosis and vascular biology2024
Trends and Updates on the Epidemiology of Cancer Associated Thrombosis: A Systematic Review.
Article in Bleeding, thrombosis and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study.American journal of hematology · 2026Article
- Development of novel plasma proteomic biomarkers for cancer-associated thrombosis in an advanced cancer cohort.Journal of thrombosis and haemostasis : JTH · 2026Article
- LMWH dose reduction in CAT: not so fast!Blood advances · 2026Article
- DETECT-VTE: an audit of patients with venous thromboembolism and their characteristics in general practice in the United Kingdom.Research and practice in thrombosis and haemostasis · 2026Article
- Extracellular Vesicles (EVs) Derived from Senescent Endothelial Cells Promote Platelet Activation.International journal of molecular sciences · 2026Article
- The public health impact of cancer-associated venous thromboembolism: looking to the future.Research and practice in thrombosis and haemostasis · 2026Article
- Automated Identification of Cancer-Associated Thrombosis Events via Natural Language Processing: A Systematic Review of the Literature.Bleeding, thrombosis and vascular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Introduction: Cancer associated thrombosis (CAT) is a significant complication for patients with cancer. This review summarizes an updated epidemiology of CAT in the past decade. Methods: A systematic review was conducted on relevant population cohort studies published 2011-2024. Results: The 12-month incidence of CAT among patients with unselected cancers is approximately 3-5% (9-fold increase vs. matched non-cancer population); although the risk increases to 6-8% in patients with advanced cancers requiring systemic therapy (20-fold increase vs. matched non-cancer population). Despite improvement in anticoagulation usage and adherence, recurrence risk remains high at 5-8% at 6 months and 7-15% at 12 months. Important clinical predictors of CAT development are cancer type, cancer stage, cancer treatment, prior venous thromboembolism (VTE) history, prolonged hospitalization or immobilization, and obesity. Several clinical risk prediction scores for CAT utilizing the initial Khorana score backbone have been externally validated, and the modified Vienna-CATS (Pabinger 2018) and EHR-CAT (Li 2023) have the highest performance (Area Under the Curve 0.68-0.71), though more studies are needed to ensure adequate implementation and usage of these models. Conclusion: CAT remains a significant complication for patients with cancer even with modern antineoplastic therapies. We encourage multidisciplinary collaborations between hematologists, oncologists, epidemiologists, and data scientists to ensure the adoption of personalized VTE risk assessment in routine oncologic care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.